Evaluation of Healing Following Open Gluteus Medius Repair With Biointegrative Implant

March 26, 2026 updated by: William Vasileff, Ohio State University

Evaluation of Healing Following Open Gluteus Medius Repair Augmented With a Biointegrative Implant

This is a prospective, single-center study design with enrollment of 15 subjects. The 15 subjects will all undergo standard gluteus medius repair that includes augmentation with the biointegrative implant. This is a small observational study. As such, we expect that the results from 15 subjects will give an adequate understanding of post surgical healing.

Study Overview

Detailed Description

Surgical gluteal tendon repair is a procedure performed regularly in operating rooms everywhere. This procedure is normally recommended to address gluteal tendon tears after nonoperative treatment options have been exhausted. However, less than satisfactory long-term outcomes can be common after open gluteal tendon repair. The augmentation of tendon repairs via various biointegrative implants is becoming more common in clinical practice, however very little, if any, of the literature details the healing after surgical intervention.

Biointegrative implants have been studied for the use of augmenting other tendon repairs, such as rotator cuff tears. Successful complete rotator cuff repairs augmented with a collagen-based implant have indicated that biointegrative implants are a safe option that may provide greater rates of healing and more positive long-term outcomes (Thon SG, 2019). Rates of healing and long-term outcomes when using a patch of this sort in other tendons such as the gluteal tendon in the hip show promise and demonstrate that there is a need for this area of study.

A 2016 study evaluated augmenting gluteus medius repair with a bioinductive implant, but the surgery was performed using endoscopic technique. There is no literature studying the healing of collagen-based implants for open gluteal tendon repairs. Although clinical outcomes show similar level of improvement for endoscopic and open gluteal tendon tear repair (Maslaris A, 2020), open repair technique with more anchors may be required for larger or more intricate tears.

This is a prospective, single-center study design with enrollment of 15 subjects. The 15 subjects will all undergo standard gluteus medius repair that includes augmentation with the biointegrative implant. This is a small observational study. As such, we expect that the results from 15 subjects will give an adequate understanding of post surgical healing.

Study Type

Observational

Enrollment (Estimated)

30

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Ohio
      • Columbus, Ohio, United States, 43202
        • Jameson Crane Sports Medicine Institute
      • Columbus, Ohio, United States, 43203
        • The Ohio State University Hospital East
      • Westerville, Ohio, United States, 43081
        • Ohio State Outpatient Care New Albany

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Patients with a gluteal tendon tear where surgical repair is indicated will be screened for inclusion. Those that meet all inclusion criteria and no exclusion criteria will be invited to participate

Description

Inclusion Criteria:

  1. Patients at least 18 years of age
  2. Patients healthy enough to undergo procedure
  3. Large partial tear and full thickness gluteal tendon tear requiring augmentation
  4. Willing and able to make all required visits
  5. Able to read and write in English

Exclusion Criteria:

  1. Hypersensitivity or objection to using bovine derived materials
  2. Significant atrophy or major retraction of gluteal tendon
  3. Women who are pregnant or nursing
  4. History of poor compliance with medical treatment
  5. Patients who are incarcerated

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Standard gluteus medius repair
Subjects will all undergo standard gluteus medius repair that includes augmentation with the biointegrative implant.
Patients will undergo standard gluteus medius repair utilizing augmentation.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Assess overall tissue quality by ultrasound assessment
Time Frame: 6 month
Graded as 'Intact/Attenuated/Disrupted'. Intact being the positive outcome, disrupted being the negative outcome.
6 month
Assess overall tissue thickness by ultrasound assessment
Time Frame: 6 month
Unit measured in centimeters
6 month
Assess overall tissue organization by ultrasound assessment
Time Frame: 6 month
Hypoechoic signal present or absent. Present being the positive outcome, absent being the negative outcome
6 month

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Modified Harris Hip Score questionnaire
Time Frame: Screening, 6 weeks, 3 month, 6 month, 12 months
Measures the functional status of the hip. Scores range from 0-100 where 100 means best functional outcome and least pain
Screening, 6 weeks, 3 month, 6 month, 12 months
International Hip Outcome Tool questionnaire
Time Frame: Screening, 6 weeks, 3 month, 6 month, 12 months
Assesses deficiencies with respect to outcome assessment of patients with hip disorders. Scores range from 0-100. Higher scores represent better quality of life.
Screening, 6 weeks, 3 month, 6 month, 12 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: William K Vasileff, MD, Ohio State University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 1, 2022

Primary Completion (Actual)

June 25, 2025

Study Completion (Estimated)

January 1, 2027

Study Registration Dates

First Submitted

August 2, 2022

First Submitted That Met QC Criteria

August 4, 2022

First Posted (Actual)

August 8, 2022

Study Record Updates

Last Update Posted (Actual)

April 1, 2026

Last Update Submitted That Met QC Criteria

March 26, 2026

Last Verified

March 1, 2026

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 2021H0451

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

IPD will not be shared

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

Yes

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Tendon Injuries

Clinical Trials on Standard gluteus medius repair with Tapestry Biointegrative implant

Subscribe